FDA Approved: METOLAZONE — Supplemental Application (Method Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for METOLAZONE submitted by Method Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Edema
• Heart Failure
• Hypertension
• Liver Cirrhosis
• Nephrotic Syndrome

Drugs mentioned

• METOLAZONE (metolazone)

Snippet

SUPPL AP for METOLAZONE (METOLAZONE)